Nonprofit Parkinson’s UK has teamed up with the University of Sheffield to create a virtual biotech.

Buoyed by a third-round fundraising that netted $51.7 million, antibiotic developer Spero Therapeutics says it will be able to accelerate clinical development…

Deborah Dunsire has achieved the rare feat, on International Women’s Day no less, of becoming CEO of an early-stage biotech after being officially named as…

Hospital group Sanford Health has invested $20 million in InGeneron to support clinical trials of a stem cell regenerative medicine.

In a typically fiery speech, President Donald Trump in his first joint address to Congress last night tore into the FDA’s “slow and burdensome approval process…

Pharma Two B has raised $30 million to complete a phase 3 trial of its Parkinson’s asset P2B001 and added ex-Pfizer CEO Jeff Kindler to its board.

Exonics Therapeutics has won $5 million in seed funding toward its goal of using cutting-edge new gene editing technology to help correct the majority of DMD…

A new upstart has launched today with the name of the planet from Frank Herbert's "Dune" as its moniker, denoting its desire to mine for potent…

Venture Capital